Work

Evaluation of immunological responses to third COVID-19 vaccine among people treated with sphingosine receptor-1 modulators and anti-CD20 therapy

Year: 2022

Type: article

Study design: Observational Study

Source: Multiple Sclerosis and Related Disorders

DOI: 10.1016/j.msard.2022.104486

Institution: Icahn School of Medicine at Mount Sinai

Language: English

Topic: SARS-CoV-2 and COVID-19 Research

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: National Institutes of Health, National Cancer Institute, National Institute of Diabetes and Digestive and Kidney Diseases

Awards: G1797781047, G20952977, G3105987405, G3174663377, G4847734291, PRIMAVO: Interactive exploration of cancer patient precision immune monitoring data in clinical trials, G9000025035, G9000187348, G9000343046

OpenAlex ID: W4313419322

FWCI: 1.696

Cites: 16

Cited by: 17

Related to: 10